Original news and analysis on international IP policy
Public interest groups in India are raising questions over annual summits involving Indian judges and policymakers that are being funded by major western industry groups, in particular pharmaceutical companies. At this year’s summit, held recently, a section of India’s patent law which prevents the extension of monopoly power for incremental innovations came under attack, the groups have said.
Reactions have emerged since last week’s release by United States Senate Judiciary Committee bipartisan leaders of details of compromise legislation to reform of US patent laws. Most are generally positive, signalling that a long-sought compromise might be near, but strong reservations remain among some stakeholders.
A representative of Google and of the United Nations International Telecommunication Union today spoke of internet freedom in repressive regimes and censorship in Western democracies.
The United States’ largest industry association today laid out an aggressive legislative agenda on intellectual property, calling for a dramatic increase in enforcement activities including pumped up customs and border authority.
A report by a United States health department advisory group issued last week presents recommendations aimed at preventing patents on genes and licensing practices in the US from negatively impacting patient access to genetic tests that would allow them to establish their genetic dispositions to declare potential illnesses.
Biotechnology lies at the intersection of a wide spectrum of fields, such as agriculture, health and environment. Because biotechnology relates to life sciences, it is often the subject of ethical, sometimes intense political debates between stakeholders, in particular involving intellectual property rights. In 2010, as the first signs of global economic recovery are emerging, the debates are expected to increase.
A key committee focused on patent law at the World Intellectual Property Organization in seeking to establish its new work programme last week discussed a proposal to better protect the confidentiality of information passed between patent advisers and their clients. But the meeting ended in no decision, and the issue is expected to come up again when the patent committee next meets in October 2010.
NEW YORK – The problem of global counterfeiting has not diminished with the new year, experts said here yesterday, and 2010 promises to bring even more rampant intellectual property theft if countries do not do more to stem the problem. Some countries are mobilising to do just that.
Along with a domestic agenda that includes patent reform and improving the efficiency of the US Patent and Trademark Office, the American Intellectual Property Law Association (AIPLA) this year also is eyeing issues at the international level, such as genetic resources, environmental technologies and international patent harmonisation.
With the United States Congress attempting to wrap up healthcare – a move made more difficult after a Republican won a traditionally Democratic US Senate seat in January - issues such as tax increases for the nation’s largest financial institutions, energy reform and others may take centre stage. But that’s not to say there is not some room for intellectual property issues to be considered. Upcoming issues may include patent reform, biologic drugs, internet neutrality, enforcement, and performance rights.
Google's William Patry discusses copyright myths, misleading metaphors, fear of new technologies and outdated business models in a video interview.
This week's consideration of an implementation plan for a medicines patent pool by the board of oversight body UNITAID stirred a stream of stakeholder letters from around the world.